These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25154262)

  • 1. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 3. Methotrexate related malignant lymphoma].
    Tokuhira M; Kizaki M
    Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1660-8. PubMed ID: 25154262
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimetabolites in combination with other drugs improve therapy of diffuse aggressive non-Hodgkin's lymphoma.
    Odujinrin OO; Bertino JR
    Cancer Invest; 1986; 4(2):139-48. PubMed ID: 3708418
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in primary CNS lymphoma.
    O'Brien PC; Seymour JF
    Lancet; 2009 Oct; 374(9700):1477-8. PubMed ID: 19767091
    [No Abstract]   [Full Text] [Related]  

  • 4. [II. Primary treatment of CNS lymphoma with high-dose MTX].
    Iwadate Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):892-7. PubMed ID: 22880222
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
    Nguyen DT; Houillier C; Choquet S; Cassoux N; Soussain C; Le Cossec C; Legarf-Tavernier M; Costopoulos M; LeHoang P; Bodaghi B; Omuro A; Hoang-Xuan K; Touitou V
    Ophthalmology; 2016 Sep; 123(9):2047-50. PubMed ID: 27137876
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary intraocular lymphoma: current and future perspectives.
    Dunleavy K; Wilson WH
    Leuk Lymphoma; 2006 Sep; 47(9):1726-7. PubMed ID: 17064977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of central nervous system malignant lymphoma].
    Nakamura O
    No To Shinkei; 2005 Dec; 57(12):1043-9. PubMed ID: 16375189
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary CNS lymphoma: a clinician's guide.
    Schäfer N; Glas M; Herrlinger U
    Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary CNS lymphoma in myasthenic on long-term azathioprine.
    Finelli PF
    J Neurooncol; 2005 Aug; 74(1):91-2. PubMed ID: 16078114
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of patients with primary central nervous system lymphoma treated with high-dose methotrexate.
    Warnick E; Auger D
    Clin J Oncol Nurs; 2009 Apr; 13(2):177-80. PubMed ID: 19349264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.
    Batchelor T; Carson K; O'Neill A; Grossman SA; Alavi J; New P; Hochberg F; Priet R
    J Clin Oncol; 2003 Mar; 21(6):1044-9. PubMed ID: 12637469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
    Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.
    O'Brien P; Roos D; Pratt G; Liew K; Barton M; Poulsen M; Olver I; Trotter G
    J Clin Oncol; 2000 Feb; 18(3):519-26. PubMed ID: 10653867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of polyglutamylation in primary central nervous system lymphoma.
    Shinojima N; Fujimoto K; Makino K; Todaka K; Yamada K; Mikami Y; Oda K; Nakamura K; Jono H; Kuratsu JI; Nakamura H; Yano S; Mukasa A
    Acta Neuropathol Commun; 2018 Feb; 6(1):15. PubMed ID: 29475458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for suspected cerebral lymphoma in AIDS.
    Alfandari S; Bourez JM; Senneville E; Maulin L; Mouton Y
    AIDS; 1998 Jul; 12(10):1246-7. PubMed ID: 9677177
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of high-dose methotrexate completion for primary central nervous system lymphoma using modified Geriatric 8 for functional assessment: A retrospective descriptive study.
    Matsunuma S; Koshiishi T; Sunaga S; Otsuka K; Okumura E; Yoshimoto K; Jimbo H
    J Geriatr Oncol; 2024 Apr; 15(3):101704. PubMed ID: 38245426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphoma of the pituitary stalk].
    Krypciak S; Alonso E; Berle M; Ajzenberg C; Combes C; Caillet P; Taillandier-Heriche E; Paillaud E
    Rev Med Interne; 2010 Feb; 31(2):140-5. PubMed ID: 19740577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
    Omuro A; Chinot O; Taillandier L; Ghesquieres H; Soussain C; Delwail V; Lamy T; Gressin R; Choquet S; Soubeyran P; Huchet A; Benouaich-Amiel A; Lebouvier-Sadot S; Gyan E; Touitou V; Barrié M; del Rio MS; Gonzalez-Aguilar A; Houillier C; Delgadillo D; Lacomblez L; Tanguy ML; Hoang-Xuan K
    Lancet Haematol; 2015 Jun; 2(6):e251-9. PubMed ID: 26688235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
    Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.